People: Abbott Laboratories (ABT)

ABT on New York Consolidated

37.48USD
23 May 2013
Price Change (% chg)

$-0.24 (-0.64%)
Prev Close
$37.72
Open
$37.49
Day's High
$37.86
Day's Low
$37.30
Volume
5,816,548
Avg. Vol
7,363,025
52-wk High
$72.47
52-wk Low
$31.64

Search Stocks

Summary

Name Age Since Current Position

Miles White

 58 1999 Chairman of the Board, Chief Executive Officer

Thomas Freyman

 58 2004 Chief Financial Officer, Executive Vice President - Finance

Hubert Allen

 47 2013 Executive Vice President, General Counsel, Secretary

Richard Ashley

 69 2004 Executive Vice President - Corporate Development

Brian Blaser

 48 2012 Executive Vice President - Diagnostics Products

John Capek

 51 2007 Executive Vice President - Medical Devices

Michael Warmuth

 50 2012 Executive Vice President - Established Pharmaceuticals

Paul Magill

 51 2012 Senior Vice President, Chief Marketing Officer

Stephen Fussell

 55 2005 Senior Vice President - Human Resources

A. David Forrest

 51 2010 Senior Vice President - International Nutrition

Heather Mason

 52 2008 Senior Vice President - Abbott Diabetes Care

Murthy Simhambhatla

 47 2013 Senior Vice President - Abbott Medical Optics

J. Scott White

 44 2010 Senior Vice President - U.S. Nutrition

Robert Alpern

 62 2008 Independent Director

Roxanne Austin

 52 2000 Independent Director

Sally Blount

 51 2011 Independent Director

W. James Farrell

 70 2006 Independent Director

Edward Liddy

 67 2010 Independent Director

Nancy McKinstry

 54 2011 Independent Director

Phebe Novakovic

 55 2010 Independent Director

William Osborn

 65 2008 Independent Director

Samuel Scott

 68 2007 Independent Director

Glenn Tilton

 64 2007 Independent Director

Brian Yoor

 2013 Vice President - Investor Relations
» Insider Trading

Biographies

Name Description

Miles White

 Mr. Miles D. White is Chairman of the Board, Chief Executive Officer of Abbott Laboratories since 1999. He served as an executive vice president of Abbott from 1998 to 1999, as senior vice president, diagnostics operations from 1994 to 1998, and as vice president, diagnostics systems operations from 1993 to 1994. Mr. White joined Abbott in 1984. He received both his bachelor's degree in mechanical engineering and M.B.A. degree from Stanford University. He serves on the board of trustees of The Culver Educational Foundation, The Field Museum in Chicago, and Northwestern University. He currently serves as a director of Caterpillar, Inc. and McDonald's Corporation. Mr. White also served on the board of directors of Motorola, Inc. from 2005 to 2009 and Tribune Company from 2005 to 2007. Serving as Abbott's chairman of the board and chief executive officer since 1999 and having joined Abbott in 1984.

Thomas Freyman

 Mr. Thomas C. Freyman is Chief Financial Officer, Executive Vice President - Finance of Abbott Laboratories. He was appointed to his current role in February 2004 and has served as Abbott's Chief Financial Officer since 2001. Mr. Freyman joined Abbott in 1979, and has served in a number of financial planning and analysis positions. In 1984, Mr. Freyman was appointed Finance Director for Abbott's European distribution center in the Netherlands. He also served as Division Controller, Corporate Materials Management, Vice President and Treasurer, and Vice President and Controller, Hospital Products Division. Prior to joining Abbott, Mr. Freyman was a Certified Public Accountant with Ernst & Whinney, Chicago. Mr. Freyman serves on the board of directors for the Chicago Botanic Garden. He is also a member of the Economic Club of Chicago, the Executives' Club of Chicago, the Healthcare Leadership Council and the S&P Corporate Ratings Issuer Council. He earned a Bachelor's degree in Accounting from the University of Illinois and a Master's degree in Management from Northwestern University.

Hubert Allen

 Mr. Hubert L. Allen is Executive Vice President, General Counsel and Secretary of Abbott Laboratories., since 2013. From 2010 to 2012 — Divisional Vice President and Associate General Counsel, Established Pharmaceuticals; 2009 to 2010 — Divisional Vice President and Associate General Counsel, Proprietary Pharmaceuticals; 2007 to 2009 — Section Head, Legal, Abbott Nutrition.

Richard Ashley

 Mr. Richard W. Ashley is Executive Vice President - Corporate Development of Abbott Laboratories since 2004. His responsibilities include various aspects of corporate strategic planning and business development. Ashley was appointed to his current position in February of 2004. Prior to joining Abbott, he was a Senior Director at McKinsey and Company, a former Managing Partner of the firm's Chicago office, and Head of the firm's Global Leadership and Organization practice. During his 31 years with McKinsey, Ashley consulted with clients in healthcare, energy and industrial manufacturing industries across a wide range of business and organizational issues. Mr. Ashley is a member of the Executive Committee of the board of directors of Junior Achievement of Chicago and a former member of the Civic Committee of the Commercial Club of Chicago. He is also a member of the American Bar Association and the Wisconsin Bar Association. He earned a Bachelor's Degree in Political Science and Master's degree in Business Administration from Northwestern University. He also holds a Juris Doctorate from the University of Wisconsin Law School.

Brian Blaser

 Mr. Brian J. Blaser is Executive Vice President - Diagnostics Products of Abbott Laboratories, since June 1, 2012. He was appointed to his current position in June 2010. Previously, Mr. Blaser served as Vice President, Diagnostics Operations; Divisional Vice President, Global Operations; and Divisional Vice President, Reagent Manufacturing, all for Abbott Diagnostics. Prior to joining Abbott, Mr. Blaser held several positions of increasing responsibility in engineering, finance and operations at Johnson & Johnson, Eastman Kodak and General Motors. He earned a bachelor's degree in mechanical engineering technology from the University of Dayton and a master's degree in business administration from Rochester Institute of Technology.

John Capek

 Mr. John M. Capek, Ph.D., is Executive Vice President - Medical Devices of Abbott Laboratories since July 2007. He is responsible for Abbott's Vascular, Diabetes Care, Ophthalmology and Animal Health businesses. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Mr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Mr. Capek was manager of New Product Technology at Eli Lilly & Company. Mr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

Michael Warmuth

 Mr. Michael J. Warmuth is Executive Vice President - Established Pharmaceuticals of Abbott Laboratories, since November 2012. Most recently, Mr. Warmuth served as Senior Vice President, Established Pharmaceuticals, which previously operated as part of Abbott’s global pharmaceutical business. Mr. Warmuth joined Abbott in 1986 as part of Abbott's manufacturing professional development program. He served in a variety of management roles including Senior Vice President, Diagnostics, heading Abbott’s global core laboratory Diagnostics business; Vice President and General Manager, Hematology, in Abbott's Diagnostics business; Vice President, Global Engineering Services; Divisional Vice President of Pharmaceutical Operations; and Divisional Vice President of Corporate Quality Operations. He earned a bachelor's degree in business administration from the University of Wisconsin-Whitewater and a master's degree in business administration from Northwestern University.

Paul Magill

 Mr. Paul K. Magill is Senior Vice President, Chief Marketing Officer of Abbott Laboratories since November 2012. Mr. Magill joined Abbott after serving as a strategic consultant on the company’s separation into two companies, Abbott and AbbVie. Prior to joining Abbott, he held numerous executive management positions, including partner for McKinsey & Co., senior partner and group leader for Monitor Group, vice president, marketing for IBM Global Services, and vice president, marketing strategy for IBM Corporation. He earned a bachelor’s degree and a master’s degree in geography and law from Cambridge University in Cambridge, United Kingdom and a master’s degree in business administration from Harvard Business School in Boston, Massachusetts.

Stephen Fussell

 Mr. Stephen R. Fussell is Senior Vice President - Human Resources of Abbott Laboratories, since April 2005. Previously, he served as Vice President, Compensation and Development. He joined Abbott in 1996, as Divisional Vice President, Compensation and Benefits. Prior to joining Abbott, Mr. Fussell was Vice President, Total Compensation and Workforce Information at Nestlé USA. Mr. Fussell is a board member for the Clara Abbott Foundation and the Abbott Fund. He earned a Bachelor's degree in Management and Administration from Louisiana State University in Baton Rouge.

A. David Forrest

 Mr. A. David Forrest is Senior Vice President - International Nutrition of Abbott Laboratories since December 2010. Previously, he served as Divisional Vice President, Europe and Canada, Abbott Nutrition International. Mr. Forrest re-joined Abbott in 2004 as general manager, Abbott International UK, having previously spent 7 years with the company from 1992 to 1999. Before returning to Abbott in 2004, Mr. Forrest worked for Pharmacia Corporation and for Pfizer Inc. as a country manager in Europe. In 2007, he joined Abbott Nutrition International as Divisional Vice President. He earned a bachelor's degree in zoology from St. Andrew’s University in Scotland.

Heather Mason

 Ms. Heather L. Mason is Senior Vice President - Abbott Diabetes Care of Abbott Laboratories since May 2008. Ms. Mason previously served as Vice President, Latin American Operations in Abbott's international pharmaceutical business. Ms. Mason joined Abbott in 1990. She held a number of positions in Abbott's U.S. pharmaceutical business, including oversight of Abbott's specialty pharmaceuticals, the diabetes/metabolics and oncology franchises, and managed health care. Ms. Mason also served as Vice President, International Marketing in Abbott's international pharmaceutical business. Prior to joining Abbott, Ms. Mason worked for Quaker Oats and FMC Corporation. Ms. Mason is an advisory board member of the Healthcare Businesswomen’s Association and Corporate Advisor for the Juvenile Diabetes Research Foundation and American Diabetes Association. She earned a Bachelor's degree in Engineering from the University of Michigan and a Master's degree in Business Administration from the University of Chicago.

Murthy Simhambhatla

 Mr. Murthy Simhambhatla is Senior Vice President - Abbott Medical Optics of Abbott Laboratories, since 2013. From 2012 — Divisional Vice President and General Manager, Abbott Medical Optics; 2011 to 2012 — Divisional Vice President and General Manager, Ibis; 2008 to 2011 - General Manager, Australia and New Zealand; 2006 to 2008 — Divisional Vice President and General Manager, Drug Eluting Stents.

J. Scott White

 Mr. J. Scott White is Senior Vice President - U.S. Nutrition of Abbott Laboratories, since 2010. He served as Division Vice President and Regional Director for Latin America, Abbott Nutrition International from 2007 to 2009 and Division Vice President and General Manager for Pediatric Nutrition, Abbott Nutrition International from 2005 to 2007.

Robert Alpern

 Dr. Robert J. Alpern, M.D., is Independent Director of Abbott Laboratories. Dr. Alpern has served as Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine since June 2004. From July 1998 to June 2004, Dr. Alpern was the Dean of The University of Texas Southwestern Medical Center. Dr. Alpern served on the Scientific Advisory Board of Ilypsa from 2004 until 2007 and since 2007 has served on the Scientific Advisory Board of Relypsa. Dr. Alpern also serves as a Director on the Board of Yale – New Haven Hospital. He has been the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine, Dean of The University of Texas Southwestern Medical Center, and as a director Yale – New Haven Hospital.

Roxanne Austin

 Mrs. Roxanne S. Austin is Independent Director of Abbott Laboratories. Ms. Austin is president of Austin Investment Advisors, a private investment and consulting firm, a position she has held since 2004. From July 2009 through July 2010, Ms. Austin also served as the president and chief executive officer of Move Networks, Inc., a provider of Internet television services. Ms. Austin served as president and chief operating officer of DIRECTV, Inc. from June 2001 to December 2003. She also served as executive vice president of Hughes Electronics Corporation and as a member of its executive committee until December 2003. From 1997 to June 2001, Ms. Austin was the corporate senior vice president and chief financial officer of Hughes Electronics Corporation. Ms. Austin is also a director of Target Corporation, Teledyne Technologies, Inc. and Telefonaktiebolaget LM Ericsson. She serves on the Board of Trustees of the California Science Center.

Sally Blount

 Ms. Sally E. Blount, Ph.D., is Independent Director of Abbott Laboratories. Ms. Blount has served as Dean of the J.L. Kellogg Graduate School of Management at Northwestern University since July 2010. From 2004 to 2010, she served as the Vice Dean and Dean of the undergraduate college of New York University's Leonard N. Stern School of Business. Ms. Blount joined the faculty of New York University's Leonard N. Stern School of Business in 2001 and was the Abraham L. Gitlow Professor of Management and Organizations. Prior to joining NYU in 2001, Ms. Blount held academic posts at the University of Chicago's Graduate School of Business from 1992 to 2001. She has been Dean of the J.L. Kellogg Graduate School of Management at Northwestern University and as the Vice Dean and Dean of the undergraduate college of New York University's Leonard N. Stern School of Business.

W. James Farrell

 Mr. W. James Farrell is Independent Director of Abbott Laboratories. Mr. Farrell served as the chairman of Illinois Tool Works Inc. from 1996 to 2006 and as its chief executive officer from 1995 to 2005. He currently serves on the board of directors of Allstate Insurance Company, UAL Corporation, and 3M. Mr. Farrell also served on the board of directors of Kraft Foods, Inc. from 2001 to 2006 and Sears, Roebuck and Company from 1999 to 2005. He has been chairman and chief executive officer of Illinois Tool Works.

Edward Liddy

 Mr. Edward M. Liddy is Independent Director of Abbott Laboratories. Mr. Liddy has been a partner in the private equity investment firm Clayton, Dubilier & Rice, LLC since January 2010, having also been a partner at such firm from April to September 2008. From September 2008 to August 2009, Mr. Liddy was the interim chairman and chief executive officer of American International Group, Inc. (AIG), a global insurance and financial services holding company. He served at AIG at the request of the U.S. Department of the Treasury in conjunction with the U.S. Government's actions to provide stability to AIG and certain other financial service firms. From January 1999 to April 2008, Mr. Liddy served as chairman of the board of the Allstate Corporation. He served as chief executive officer of Allstate from January 1999 to December 2006, President from January 1995 to May 2005, and chief operating officer from August 1994 to January 1999. Mr. Liddy currently serves on the board of directors of 3M Company and The Boeing Company. In addition, Mr. Liddy formerly served on the boards of The Kroger Co. from 1996 to 2006, The Goldman Sachs Group, Inc. from 2003 to 2008, and The Boeing Company from 2007 to 2008. Mr. Liddy received his undergraduate degree from Catholic University and his Masters of Business Administration from George Washington University. He has been chairman and chief executive officer of Allstate Corporation and American International Group, Inc.

Nancy McKinstry

 Ms. Nancy McKinstry is Independent Director of Abbott Laboratories. Ms. McKinstry has been chief executive officer and chairman of the executive board of Wolters Kluwer N.V. since September 2003 and a member of its executive board since June 2001. Ms. McKinstry serves on the board of directors of Sanoma Corporation and Telefonaktiebolaget LM Ericsson (LM Ericsson Telephone Company). Ms. McKinstry also served on the board of directors of MortgageIT Holdings, Inc. from 2004 to 2007. She has been the chief executive officer and chairman of the executive board of Wolters Kluwer N.V.

Phebe Novakovic

 Ms. Phebe N. Novakovic is Independent Director of Abbott Laboratories. Ms. Novakovic has been executive vice president, Marine Systems of General Dynamics Corporation since May 2010 and from May 2005 to April 2010, Ms. Novakovic served as its senior vice president – planning and development. She was elected vice president of General Dynamics in October 2002 after joining the company in May 2001. Previously, Ms. Novakovic was special assistant to the Secretary and Deputy Secretary of Defense, and had been a deputy associate director of the Office of Management and Budget. As the executive vice president and group executive of General Dynamics Corporation's Marine Systems group, Ms. Novakovic has management experience with a public company, including marketing, operational and manufacturing experience.

William Osborn

 Mr. William A. Osborn is Independent Director of Abbott Laboratories. Mr. Osborn was chairman of Northern Trust Corporation from 1995 through 2009 and served as its chief executive officer from 1995 through 2007. Mr. Osborn currently serves as director of Caterpillar Inc., General Dynamics Corporation, and Tribune Company. He is chairman of the Board of Trustees of Northwestern University and also serves as chairman of the Chicago Symphony Orchestra Association. Mr. Osborn served on the board of directors of Nicor, Inc. from 1999 to 2006. He holds a B.A. degree and an M.B.A. degree from Northwestern University. He has been chairman and chief executive officer of Northern Trust Corporation and The Northern Trust Company.

Samuel Scott

 Mr. Samuel C. Scott, III., is Independent Director of Abbott Laboratories., since 2007. Mr. Scott retired as chairman, president and chief executive officer of Corn Products International in 2009, after having served in those positions since 1997. He was president of the Corn Refining Division of CPC International from 1995 through 1997, when CPC International spun off Corn Products International as a separate corporation. Mr. Scott currently serves on the board of directors of Bank of New York Mellon Corporation, Motorola Solutions, Inc. (formerly Motorola, Inc.), the Chicago Council on Global Affairs, the Chicago Urban League, Northwestern Healthcare, and Chicago Sister Cities. Mr. Scott graduated from Fairleigh Dickinson University. He has been chairman, president and chief executive officer of Corn Products International.

Glenn Tilton

 Mr. Glenn F. Tilton is an Independent Director of Abbott Laboratories. In 2011, Mr. Tilton became chairman of the Midwest for JPMorgan Chase & Co. and member of its companywide executive committee. Since October 2010, Mr. Tilton has also been non-executive chairman of the board of United Continental Holdings, Inc. From September 2002 to October 2010, he served as chairman, president and chief executive officer of UAL Corporation, a holding company, and United Air Lines, Inc., an air transportation company and wholly owned subsidiary of UAL Corporation. UAL Corporation filed a voluntary bankruptcy petition under the federal bankruptcy laws in December 2002 and exited bankruptcy in February 2006. Prior to joining United and having completed the merger of Texaco and Chevron, Mr. Tilton served as vice chairman of the board of Chevron Texaco Corporation (global energy) as well as interim chairman of Dynegy, Inc. (energy). Previously, he served as chairman and chief executive officer of Texaco Inc. (global energy). Mr. Tilton is also a director of United Continental Holdings, Inc., Corning Incorporated. Mr. Tilton also served on the board of directors of Lincoln National Corporation from 2002 to 2007 and of TXU Corporation from 2005 to 2007. He has been chairman of the Midwest for JPMorgan Chase & Co. and non-executive chairman of the board of United Continental Holdings, Inc., and having previously served as chairman, president, and chief executive officer of UAL Corporation and United Air Lines, vice chairman of Chevron Texaco and as interim chairman of Dynegy, Inc.

Brian Yoor

 Mr. Brian Yoor currently serves as Vice President - Investor Relations of Abbott Laboratories. He has been with Abbott in numerous financial roles for 15 years, most recently as Controller of Abbott Laboratories Diagnostics division.

Insider Trading

Name Shares Traded Price

WARMUTH MICHAEL J

 3,960 $37.06

MCKINSTRY NANCY

 3,097 $0.00

FARRELL W JAMES

 3,097 $0.00

AUSTIN ROXANNE SCHUH

 3,097 $0.00

SCOTT SAMUEL C III

 3,097 $0.00

NOVAKOVIC PHEBE N

 3,097 $0.00

TILTON GLENN FLETCHER

 3,097 $0.00

LIDDY EDWARD M

 3,097 $0.00

ALPERN ROBERT J

 3,097 $0.00

OSBORN WILLIAM A

 3,097 $0.00

BLOUNT SALLY E

 3,097 $0.00

FREYMAN THOMAS C

 63,800 $22.27

FREYMAN THOMAS C

 50,917 $35.32

FOLTZ CHARLES D

 14,800 $0.00

FREYMAN THOMAS C

 42,487 $34.93

FREYMAN THOMAS C

 33,180 $25.25

FREYMAN THOMAS C

 16,384 $26.09

WHITE J SCOTT

 11,520 $34.26

FORREST A DAVID

 8,563 $34.26

MASON HEATHER L

 11,255 $34.26

FUSSELL STEPHEN R

 11,974 $34.26

FORREST A DAVID

 16,466 $0.00

ASHLEY RICHARD W

 18,984 $34.26

LINDER GREG W

 9,188 $34.26

WARMUTH MICHAEL J

 10,838 $34.26
» Full list on Insider Trading
Search Stocks